Reshma Rangwala
2021
In 2021, Reshma Rangwala earned a total compensation of $594.4K as Former Chief Medical Officer at Versartis, a 30% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $124,500 |
|---|---|
| Option Awards | $49,957 |
| Salary | $415,000 |
| Other | $4,971 |
| Total | $594,428 |
Rangwala received $415K in salary, accounting for 70% of the total pay in 2021.
Rangwala also received $124.5K in non-equity incentive plan, $50K in option awards and $5K in other compensation.
Rankings
In 2021, Reshma Rangwala's compensation ranked 10,334th out of 12,397 executives tracked by ExecPay. In other words, Rangwala earned more than 16.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,334 out of 12,397 | 17th |
Division Manufacturing | 4,570 out of 5,492 | 17th |
Major group Chemicals And Allied Products | 2,045 out of 2,367 | 14th |
Industry group Drugs | 1,816 out of 2,090 | 13th |
Industry Pharmaceutical Preparations | 1,346 out of 1,537 | 12th |
Source: SEC filing on August 4, 2022.
Rangwala's colleagues
We found two more compensation records of executives who worked with Reshma Rangwala at Versartis in 2021.